-
BioSante Pharma (BPAX) Announces $15M Registered Direct Offering
-
BioSante Pharma (BPAX) Closes 10.4M Common Registered Direct Offering; $18M in Gross Proceeds
-
BioSante Pharma (BPAX) to Raise $17.5M in Direct Offering of Common Stock and Warrants
